Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Pediatric Neurology Device market is going through powerful changes driven by mechanical advancements, increasing awareness of pediatric neurological disorders, and a developing emphasis on early diagnosis and mediation. This market plays a critical job in giving clinical devices custom-made to address the one-of-a-kind neurological need of children, covering a scope of conditions from epilepsy to neurodevelopmental disorders.
There is a developing emphasis on early mediation in pediatric neurology, influencing market dynamics. Clinical devices designed for formative neurology, including checking systems for early signs of neurological disorders, are acquiring significance in further developing outcomes for children with neurological challenges.
The increasing frequency of pediatric neurological disorders is a critical driver in market dynamics. Conditions such as autism spectrum disorders, attention deficit hyperactivity disorder (ADHD), and epilepsy are adding to the developing interest for specialized neurology devices for children.
Wearable and compact devices are acquiring noticeable quality in pediatric neurology, affecting market dynamics. Innovations such as compact EEG monitors and walking checking systems give greater adaptability in observing neurological action, empowering continuous information assortment outside customary clinical settings.
The coming of precision medication and advancements in pediatric neurogenetics are shaping the market. Genetic testing and personalized treatment approaches based on a singular child's genetic profile add to focused on and successful interventions, impacting market dynamics in pediatric neurology.
Parental association in the selection of neurology devices for their children is affecting market dynamics. Device manufacturers consider the preferences, ease of use, and comfort levels for parents and caregivers, affecting the reception rates of pediatric neurology devices.
The market dynamics are advancing with the mix of telehealth and remote checking solutions in pediatric neurology. These technologies improve accessibility to neurological consideration, empowering remote consultations, observing, and follow-up, adding to more persistent driven and inclusive consideration models.
Global Pediatric Neurology Devices Market Highlights:
Global Pediatric Neurology Devices Market Overview
The pediatric neurology devices market is anticipated to reach USD 3,241.68 Million by 2030 at 4.5% CAGR during the forecast period 2022-2030. Pediatric neurology is a branch of science referring to neurological disorders in children such as insomnia and frequent headaches. The prevalence of neurological disorders in children is rising rapidly. Neurological disorders are diseases of spine, brain, and nerves that connect them. Approx. 600 diseases of the nervous system are present across the world. However, there are many devices introduced by the market players for the diagnosis and treatment of neurological disorders in children.
Neurological disorders are either lower risk disorders or major risk disorders. Lower risk disorders include insomnia, delayed speech, poor muscle tone, and frequent headaches, whereas major risk disorders include head and spinal cord trauma, infections or inflammatory processes, neuro-genetic disorder, epilepsy, seizures, and others. Various pediatric neurology devices are available in the market, which are used for the treatment of neurological disorders in children. These devices are designed such that it can be used for the treatment of a wide range of neurological disorders. Pediatric neurology devices market growth is majorly attributed to the increasing prevalence of neurological disorders and other related problems across the globe. According to the Migraine Research Foundation report, it has been observed that half of all migraine sufferers have their first attack before the age of 12 and migraine has even been reported to in 18 months old children. Additionally, the prevalence of epilepsy in children appears to be lower in developed countries and highest in rural areas of underdeveloped countries.
Moreover, the government of developing countries are looking forward to adopting advanced technology from the developed nations to improve the quality of life of their citizen and also support the launch of medical devices for treating and helping children with neurological disorders. However, the high cost associated with monitoring and diagnosis of the neurological diseases may restrain the market growth.
In this breakthrough alliance between Healing Innovations, a major medical technology provider and Arkansas Children’s Hospital in April 2024, Rise&Walk technology—customized for aiding children through the rehabilitation process after spinal cord and traumatic brain injuries—was developed for the first time.
OrthoPediatrics announced early in January 2024 that it had acquired Boston Orthotics & Prosthetics at an undisclosed amount. In addition to the acquisition, OrthoPediatrics has signed a debt financing agreement with MidCap Financial and could raise up to $80 million of capital by combining a term loan with the revolving loan, replacing the previous unused $50 million line of credit.
Oxford Nanopore Technologies teamed up with American firm Fabric Genomics in October 2023 to create software capable of analyzing and reporting genomic information from neonatal and pediatric patients in ICUs.
Axoft launched its brain-machine interface (BMI) for the treatment of long-term neurological disorders with the FDA Breakthrough Device designation in October 2022. This minimally invasive device offers electrical stability to monitor brain signals and a high number of sensors per volume unit on it to optimize the amount of information that can be communicated between living brains and circuits.
Abbott got US Food and Drug Administration (FDA) approval for its new spinal cord stimulation device—a new modality called FlexBurst360™ therapy within the Proclaim™ Plus spinal cord stimulation (SCS) system—in August 2022. It provides pain coverage over as many as six sites on limbs while mimicking natural patterns observed inside human brain neurons.
Medtronic plc disclosed United States FDA clearance news in July 2021, where they performed their initial operations related to Deep Brain Stimulation (DBS) using the SenSight directional lead system. The SenSight was a one-of-a-kind DBS directional lead that combined directionality advantages with sensing capabilities, thus allowing physicians to achieve accurate patient-specific DBS therapy addressing certain movement disorders symptoms such as Parkinson’s disease, dystonia and essential tremor, and medically refractory epilepsy.
gammaCore Sapphire was approved by the US Food and Drug Administration (FDA) in February 2021 as an acute, preventive treatment for migraine in adolescents aged between twelve to seventeen years. It is a handheld, non-invasive device that applies a low-voltage electric signal resulting in an electrical field close to the vagus nerve thereby averting and relieving headaches without any need to undergo surgery.
Pediatric Neurology Devices Market Segment Insights
The pediatric neurology devices market is segmented on the basis of type, service and treatment, neurological subspecialties, age group, and end user
Pediatric Neurology Devices Type Insights
By type, the pediatric neurology devices market is segmented into neurosurgery devices, neurostimulator, cerebrospinal fluid (CSF) management devices, and others.
Pediatric Neurology Devices Service & Treatment Insights
On the basis of service and treatment, pediatric neurology devices market is segmented into electroencephalogram, intrathecal baclofen therapy, neurological evaluations, vagal nerve stimulation, and others.
On the basis of the neurological subspecialties, pediatric neurology devices market is segmented into neuro-oncology, neuromuscular, neonatal neurology, neuro-immunology, stroke, and others.
Pediatric Neurology Devices Age Group Insights
On the basis of the age group, pediatric neurology devices market is segmented into neonates, infants, children, and adolescents
Pediatric Neurology Devices End-User Insights
On the basis of the end user, pediatric neurology devices market is segmented into hospitals, healthcare centers, neurological research centers, and others.
Pediatric Neurology Devices Regional Insights
The Americas dominate the market owing to the rising prevalence of disease such as depression, epilepsy, and migraine, high healthcare spending, and increasing government support for research & development. According to a report published by the Centers for Disease Control and Prevention in 2017, more than 470,000 children below 17 years have epilepsy. Additionally, According to the Migraine Research Foundation, (2014), migraine was the 3rd most prevalent illness in the world. Nearly 1 in 4 U.S. households includes a migraine patient.
Europe holds the second position in the market owing to the government support for research & development and availability of funds for research. Moreover, people of this region have more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.
Asia Pacific is considering the huge market for pediatric neurology devices market players owing to the presence of huge patient population in countries like India and china. Moreover, high health care expenditure, adding the fuel to this market. Additionally, countries from this region looking forward to adopt advanced technology and treatment from developed nations to improve the quality of life for their citizen.
Whereas the Middle East and Africa are considering the low market due to incapability of investment and poor healthcare infrastructure.
Key Players
- Elana, Inc. (the Netherlands)
- Ethicon Inc. (U.S.)
- Inova Health System (U.S.)
- Medtronic (U.S.)
- The Nemours Foundation (U.S.)
- Stryker Corporation (U.S.)
- Boston Scientific Corporation (U.S.)
- B.Braun Melsungen AG (Germany)
- Integra LifeSciences Corporation (U.S.)
- St. Jude Medical, LLC (U.S.)
Intended Audience
- Pediatric Neurology Device Manufacturers
- Pediatric Neurology Device Suppliers & Distributors
- Neurological Hospitals and Clinics
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
